Skip to main content
Top
Published in: Respiratory Research 1/2012

Open Access 01-12-2012 | Research

Gene expression analysis of a murine model with pulmonary vascular remodeling compared to end-stage IPAH lungs

Authors: Kayoko Shimodaira, Yoichiro Okubo, Eri Ochiai, Haruo Nakayama, Harutaka Katano, Megumi Wakayama, Minoru Shinozaki, Takao Ishiwatari, Daisuke Sasai, Naobumi Tochigi, Tetsuo Nemoto, Tsutomu Saji, Katsuhiko Kamei, Kazutoshi Shibuya

Published in: Respiratory Research | Issue 1/2012

Login to get access

Abstract

Background

Idiopathic pulmonary arterial hypertension (IPAH) continues to be one of the most serious intractable diseases that might start with activation of several triggers representing the genetic susceptibility of a patient. To elucidate what essentially contributes to the onset and progression of IPAH, we investigated factors playing an important role in IPAH by searching discrepant or controversial expression patterns between our murine model and those previously published for human IPAH. We employed the mouse model, which induced muscularization of pulmonary artery leading to hypertension by repeated intratracheal injection of Stachybotrys chartarum, a member of nonpathogenic and ubiquitous fungus in our envelopment.

Methods

Microarray assays with ontology and pathway analyses were performed with the lungs of mice. A comparison was made of the expression patterns of biological pathways between our model and those published for IPAH.

Results

Some pathways in our model showed the same expression patterns in IPAH, which included bone morphogenetic protein (BMP) signaling with down-regulation of BMP receptor type 2, activin-like kinase type 1, and endoglin. On the other hand, both Wnt/planar cell polarity (PCP) signaling and its downstream Rho/ROCK signaling were found alone to be activated in IPAH and not in our model.

Conclusions

Activation of Wnt/PCP signaling, in upstream positions of the pathway, found alone in lungs from end stage IPAH may play essential roles in the pathogenesis of the disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009, 54: S43-S54. 10.1016/j.jacc.2009.04.012.PubMedCrossRef Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009, 54: S43-S54. 10.1016/j.jacc.2009.04.012.PubMedCrossRef
2.
go back to reference Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S: An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007, 30: 104-109. 10.1183/09031936.00092306.PubMedCrossRef Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S: An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007, 30: 104-109. 10.1183/09031936.00092306.PubMedCrossRef
3.
go back to reference Sankelo M, Flanagan JA, Machado R, Harrison R, Rudarakanchana N, Morrell N, Dixon M, Halme M, Puolijoki H, Kere J, Elomaa O, Kupari M, Räisänen-Sokolowski A, Trembath RC, Laitinen T: BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension. Hum Mutat. 2005, 26: 119-124. 10.1002/humu.20200.PubMedCrossRef Sankelo M, Flanagan JA, Machado R, Harrison R, Rudarakanchana N, Morrell N, Dixon M, Halme M, Puolijoki H, Kere J, Elomaa O, Kupari M, Räisänen-Sokolowski A, Trembath RC, Laitinen T: BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension. Hum Mutat. 2005, 26: 119-124. 10.1002/humu.20200.PubMedCrossRef
4.
go back to reference Newman JH, Trembath RC, Morse JA, Grunig E, Loyd JE, Adnot S, Coccolo F, Ventura C, Phillips JA, Knowles JA, Janssen B, Eickelberg O, Eddahibi S, Herve P, Nichols WC, Elliott G: Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol. 2004, 43: 33S-39S. 10.1016/j.jacc.2004.02.028.PubMedCrossRef Newman JH, Trembath RC, Morse JA, Grunig E, Loyd JE, Adnot S, Coccolo F, Ventura C, Phillips JA, Knowles JA, Janssen B, Eickelberg O, Eddahibi S, Herve P, Nichols WC, Elliott G: Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol. 2004, 43: 33S-39S. 10.1016/j.jacc.2004.02.028.PubMedCrossRef
6.
go back to reference Ochiai E, Kamei K, Watanabe A, Nagayoshi M, Tada Y, Nagaoka T, Sato K, Sato A, Shibuya K: Inhalation of Stachybotrys chartarum causes pulmonary arterial hypertension in mice. Int J Exp Pathol. 2008, 89: 201-208. 10.1111/j.1365-2613.2008.00585.x.PubMedPubMedCentralCrossRef Ochiai E, Kamei K, Watanabe A, Nagayoshi M, Tada Y, Nagaoka T, Sato K, Sato A, Shibuya K: Inhalation of Stachybotrys chartarum causes pulmonary arterial hypertension in mice. Int J Exp Pathol. 2008, 89: 201-208. 10.1111/j.1365-2613.2008.00585.x.PubMedPubMedCentralCrossRef
7.
go back to reference Black JA, Dean TR, Foarde K, Menetrez M: Detection of Stachybotrys chartarum using rRNA, tri5, and beta-tubulin primers and determining their relative copy number by real-time PCR. Mycol Res. 2008, 112: 845-851. 10.1016/j.mycres.2008.01.006.PubMedCrossRef Black JA, Dean TR, Foarde K, Menetrez M: Detection of Stachybotrys chartarum using rRNA, tri5, and beta-tubulin primers and determining their relative copy number by real-time PCR. Mycol Res. 2008, 112: 845-851. 10.1016/j.mycres.2008.01.006.PubMedCrossRef
8.
go back to reference Black JA, Foarde KK: Comparison of four different methods for extraction of Stachybotrys chartarum spore DNA and verification by real-time PCR. J Microbiol Methods. 2007, 70: 75-81. 10.1016/j.mimet.2007.03.017.PubMedCrossRef Black JA, Foarde KK: Comparison of four different methods for extraction of Stachybotrys chartarum spore DNA and verification by real-time PCR. J Microbiol Methods. 2007, 70: 75-81. 10.1016/j.mimet.2007.03.017.PubMedCrossRef
9.
go back to reference Groshong SD, Tomashefski JF, Cool CD: Pulmonary Hypertensive vascular Disease. Dail and Hammar’s pulmonary pathology. Volume 1. Edited by: Tomashefski JF Jr. 2008, New York: Springer, 1032-1087. 3CrossRef Groshong SD, Tomashefski JF, Cool CD: Pulmonary Hypertensive vascular Disease. Dail and Hammar’s pulmonary pathology. Volume 1. Edited by: Tomashefski JF Jr. 2008, New York: Springer, 1032-1087. 3CrossRef
10.
go back to reference Pepper SD, Saunders EK, Edwards LE, Wilson CL, Miller CJ: The utility of MAS5 expression summary and detection call algorithms. BMC Bioinforma. 2007, 8: 273-10.1186/1471-2105-8-273.CrossRef Pepper SD, Saunders EK, Edwards LE, Wilson CL, Miller CJ: The utility of MAS5 expression summary and detection call algorithms. BMC Bioinforma. 2007, 8: 273-10.1186/1471-2105-8-273.CrossRef
11.
go back to reference Maere S, Heymans K, Kuiper M: BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics. 2005, 21: 3448-3449. 10.1093/bioinformatics/bti551.PubMedCrossRef Maere S, Heymans K, Kuiper M: BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics. 2005, 21: 3448-3449. 10.1093/bioinformatics/bti551.PubMedCrossRef
12.
go back to reference Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B, Jupe S, Kalatskaya I, Mahajan S, May B, Ndegwa N, Schmidt E, Shamovsky V, Yung C, Birney E, Hermjakob H, D'Eustachio P, Stein L: Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011, 39: D691-D697. 10.1093/nar/gkq1018.PubMedPubMedCentralCrossRef Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B, Jupe S, Kalatskaya I, Mahajan S, May B, Ndegwa N, Schmidt E, Shamovsky V, Yung C, Birney E, Hermjakob H, D'Eustachio P, Stein L: Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011, 39: D691-D697. 10.1093/nar/gkq1018.PubMedPubMedCentralCrossRef
13.
go back to reference Barrell D, Dimmer E, Huntley RP, Binns D, O'Donovan C, Apweiler R: The GOA database in 2009-an integrated gene ontology annotation resource. Nucleic Acids Res. 2009, 37: D396-D403. 10.1093/nar/gkn803.PubMedPubMedCentralCrossRef Barrell D, Dimmer E, Huntley RP, Binns D, O'Donovan C, Apweiler R: The GOA database in 2009-an integrated gene ontology annotation resource. Nucleic Acids Res. 2009, 37: D396-D403. 10.1093/nar/gkn803.PubMedPubMedCentralCrossRef
14.
go back to reference Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M: KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38: D355-D360. 10.1093/nar/gkp896.PubMedPubMedCentralCrossRef Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M: KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38: D355-D360. 10.1093/nar/gkp896.PubMedPubMedCentralCrossRef
15.
go back to reference Rajkumar R, Konishi K, Richards TJ, Ishizawar DC, Wiechert AC, Kaminski N, Ahmad F: Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2010, 298: H1235-H1248. 10.1152/ajpheart.00254.2009.PubMedPubMedCentralCrossRef Rajkumar R, Konishi K, Richards TJ, Ishizawar DC, Wiechert AC, Kaminski N, Ahmad F: Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2010, 298: H1235-H1248. 10.1152/ajpheart.00254.2009.PubMedPubMedCentralCrossRef
16.
go back to reference Fantozzi I, Huang W, Zhang J, Zhang S, Platoshyn O, Remillard CV, Thistlethwaite PA, Yuan JX: Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension. Exp Lung Res. 2005, 31: 783-806. 10.1080/01902140500461026.PubMedPubMedCentralCrossRef Fantozzi I, Huang W, Zhang J, Zhang S, Platoshyn O, Remillard CV, Thistlethwaite PA, Yuan JX: Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension. Exp Lung Res. 2005, 31: 783-806. 10.1080/01902140500461026.PubMedPubMedCentralCrossRef
17.
go back to reference Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M, Dartevelle P, Simonneau G, Adnot S, Eddahibi S: Role of endothelium-derived CC Chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2007, 176: 1041-1047. 10.1164/rccm.200610-1559OC.PubMedCrossRef Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M, Dartevelle P, Simonneau G, Adnot S, Eddahibi S: Role of endothelium-derived CC Chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2007, 176: 1041-1047. 10.1164/rccm.200610-1559OC.PubMedCrossRef
18.
go back to reference Masri FA, Xu W, Comhair SA, Asosingh K, Koo M, Vasanji A, Drazba J, Anand-Apte B, Erzurum SC: Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2007, 293: L548-L554. 10.1152/ajplung.00428.2006.PubMedCrossRef Masri FA, Xu W, Comhair SA, Asosingh K, Koo M, Vasanji A, Drazba J, Anand-Apte B, Erzurum SC: Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2007, 293: L548-L554. 10.1152/ajplung.00428.2006.PubMedCrossRef
19.
go back to reference Hecker M, Zaslona Z, Kwapiszewska G, Niess G, Zakrzewicz A, Hergenreider E, Wilhelm J, Marsh LM, Sedding D, Klepetko W, Lohmeyer J, Dimmeler S, Seeger W, Weissmann N, Schermuly RT, Kneidinger N, Eickelberg O, Morty RE: Dysregulation of the IL-13 receptor system a novel pathomechanism in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010, 182: 805-818. 10.1164/rccm.200909-1367OC.PubMedCrossRef Hecker M, Zaslona Z, Kwapiszewska G, Niess G, Zakrzewicz A, Hergenreider E, Wilhelm J, Marsh LM, Sedding D, Klepetko W, Lohmeyer J, Dimmeler S, Seeger W, Weissmann N, Schermuly RT, Kneidinger N, Eickelberg O, Morty RE: Dysregulation of the IL-13 receptor system a novel pathomechanism in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010, 182: 805-818. 10.1164/rccm.200909-1367OC.PubMedCrossRef
20.
go back to reference Courboulin A, Paulin R, Giguère NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Côté J, Simard MJ, Bonnet S: Role for miR-204 in human pulmonary arterial hypertension. J. Exp. Med. 2011, 208: 535-548. 10.1084/jem.20101812.PubMedPubMedCentralCrossRef Courboulin A, Paulin R, Giguère NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Côté J, Simard MJ, Bonnet S: Role for miR-204 in human pulmonary arterial hypertension. J. Exp. Med. 2011, 208: 535-548. 10.1084/jem.20101812.PubMedPubMedCentralCrossRef
21.
go back to reference Dewachter L, Adnot S, Fadel E, Humbert M, Maitre B, Barlier-Mur AM, Simonneau G, Hamon M, Naeije R, Eddahibi S: Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. Am J Respir Crit Care Med. 2006, 174: 1025-1033. 10.1164/rccm.200602-304OC.PubMedCrossRef Dewachter L, Adnot S, Fadel E, Humbert M, Maitre B, Barlier-Mur AM, Simonneau G, Hamon M, Naeije R, Eddahibi S: Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. Am J Respir Crit Care Med. 2006, 174: 1025-1033. 10.1164/rccm.200602-304OC.PubMedCrossRef
22.
go back to reference Yu Y, Keller SH, Remillard CV, Safrina O, Nicholson A, Zhang SL, Jiang W, Vangala N, Landsberg JW, Wang JY, Thistlethwaite PA, Channick RN, Robbins IM, Loyd JE, Ghofrani HA, Grimminger F, Schermuly RT, Cahalan MD, Rubin LJ, Yuan JX: A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation. 2009, 119: 2313-2322. 10.1161/CIRCULATIONAHA.108.782458.PubMedPubMedCentralCrossRef Yu Y, Keller SH, Remillard CV, Safrina O, Nicholson A, Zhang SL, Jiang W, Vangala N, Landsberg JW, Wang JY, Thistlethwaite PA, Channick RN, Robbins IM, Loyd JE, Ghofrani HA, Grimminger F, Schermuly RT, Cahalan MD, Rubin LJ, Yuan JX: A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation. 2009, 119: 2313-2322. 10.1161/CIRCULATIONAHA.108.782458.PubMedPubMedCentralCrossRef
23.
go back to reference Lepetit H, Eddahibi S, Fadel E, Frisdal E, Munaut C, Noel A, Humbert M, Adnot S, D'Ortho MP, Lafuma C: Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J. 2005, 25: 834-842. 10.1183/09031936.05.00072504.PubMedCrossRef Lepetit H, Eddahibi S, Fadel E, Frisdal E, Munaut C, Noel A, Humbert M, Adnot S, D'Ortho MP, Lafuma C: Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J. 2005, 25: 834-842. 10.1183/09031936.05.00072504.PubMedCrossRef
24.
go back to reference Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S: Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest. 2001, 108: 1141-1150.PubMedPubMedCentralCrossRef Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S: Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest. 2001, 108: 1141-1150.PubMedPubMedCentralCrossRef
25.
go back to reference Perros F, Montani D, Dorfmüller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Hervé P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M: Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008, 178: 81-88. 10.1164/rccm.200707-1037OC.PubMedCrossRef Perros F, Montani D, Dorfmüller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Hervé P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M: Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008, 178: 81-88. 10.1164/rccm.200707-1037OC.PubMedCrossRef
26.
go back to reference Do e Z, Fukumoto Y, Takaki A, Tawara S, Ohashi J, Nakano M, Tada T, Saji K, Sugimura K, Fujita H, Hoshikawa Y, Nawata J, Kondo T, Shimokawa H: Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circ J. 2009, 73: 1731-1739. 10.1253/circj.CJ-09-0135.PubMedCrossRef Do e Z, Fukumoto Y, Takaki A, Tawara S, Ohashi J, Nakano M, Tada T, Saji K, Sugimura K, Fujita H, Hoshikawa Y, Nawata J, Kondo T, Shimokawa H: Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circ J. 2009, 73: 1731-1739. 10.1253/circj.CJ-09-0135.PubMedCrossRef
27.
go back to reference Laumanns IP, Fink L, Wilhelm J, Wolff JC, Mitnacht-Kraus R, Graef-Hoechst S, Stein MM, Bohle RM, Klepetko W, Hoda MA, Schermuly RT, Grimminger F, Seeger W, Voswinckel R: The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2009, 40: 683-691. 10.1165/rcmb.2008-0153OC.PubMedCrossRef Laumanns IP, Fink L, Wilhelm J, Wolff JC, Mitnacht-Kraus R, Graef-Hoechst S, Stein MM, Bohle RM, Klepetko W, Hoda MA, Schermuly RT, Grimminger F, Seeger W, Voswinckel R: The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2009, 40: 683-691. 10.1165/rcmb.2008-0153OC.PubMedCrossRef
28.
go back to reference Golpon HA, Geraci MW, Moore MD, Miller HL, Miller GJ, Tuder RM, Voelkel NF: HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol. 2001, 158: 955-966. 10.1016/S0002-9440(10)64042-4.PubMedPubMedCentralCrossRef Golpon HA, Geraci MW, Moore MD, Miller HL, Miller GJ, Tuder RM, Voelkel NF: HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol. 2001, 158: 955-966. 10.1016/S0002-9440(10)64042-4.PubMedPubMedCentralCrossRef
29.
go back to reference Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF: Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 2009, 297: L1013-L1032. 10.1152/ajplung.00217.2009.PubMedCrossRef Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF: Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 2009, 297: L1013-L1032. 10.1152/ajplung.00217.2009.PubMedCrossRef
30.
go back to reference Rabinovitch M: Cellular and molecular pathobiology of pulmonary hypertension conference summary. Chest. 2005, 128: 642S-646S. 10.1378/chest.128.6_suppl.642S.PubMedCrossRef Rabinovitch M: Cellular and molecular pathobiology of pulmonary hypertension conference summary. Chest. 2005, 128: 642S-646S. 10.1378/chest.128.6_suppl.642S.PubMedCrossRef
31.
go back to reference Moreno-Vinasco L, Gomberg-Maitland M, Maitland ML, Desai AA, Singleton PA, Sammani S, Sam L, Liu Y, Husain AN, Lang RM, Ratain MJ, Lussier YA, Garcia JG: Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics. 2008, 33: 278-291. 10.1152/physiolgenomics.00169.2007.PubMedPubMedCentralCrossRef Moreno-Vinasco L, Gomberg-Maitland M, Maitland ML, Desai AA, Singleton PA, Sammani S, Sam L, Liu Y, Husain AN, Lang RM, Ratain MJ, Lussier YA, Garcia JG: Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics. 2008, 33: 278-291. 10.1152/physiolgenomics.00169.2007.PubMedPubMedCentralCrossRef
32.
go back to reference Kwapiszewska G, Wilhelm J, Wolff S, Laumanns I, Koenig IR, Ziegler A, Seeger W, Bohle RM, Weissmann N, Fink L: Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension. Respir Res. 2005, 6: 109-10.1186/1465-9921-6-109.PubMedPubMedCentralCrossRef Kwapiszewska G, Wilhelm J, Wolff S, Laumanns I, Koenig IR, Ziegler A, Seeger W, Bohle RM, Weissmann N, Fink L: Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension. Respir Res. 2005, 6: 109-10.1186/1465-9921-6-109.PubMedPubMedCentralCrossRef
33.
go back to reference Vaszar LT, Nishimura T, Storey JD, Zhao G, Qiu D, Faul JL, Pearl RG, Kao PN: Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats. Physiol Genomics. 2004, 17: 150-156. 10.1152/physiolgenomics.00198.2003.PubMedCrossRef Vaszar LT, Nishimura T, Storey JD, Zhao G, Qiu D, Faul JL, Pearl RG, Kao PN: Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats. Physiol Genomics. 2004, 17: 150-156. 10.1152/physiolgenomics.00198.2003.PubMedCrossRef
34.
go back to reference Pestka JJ, Yike I, Dearborn DG, Ward MD, Harkema JR: Stachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: new insights into a public health enigma. Toxicol Sci. 2008, 104: 4-26. 10.1093/toxsci/kfm284.PubMedCrossRef Pestka JJ, Yike I, Dearborn DG, Ward MD, Harkema JR: Stachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: new insights into a public health enigma. Toxicol Sci. 2008, 104: 4-26. 10.1093/toxsci/kfm284.PubMedCrossRef
35.
go back to reference Chida A, Shintani M, Nakayama T, Furutani Y, Hayama E, Inai K, Saji T, Nonoyama S, Nakanishi T: Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension. Circ J. 2012, 76: 1501-1508. 10.1253/circj.CJ-11-1281.PubMedCrossRef Chida A, Shintani M, Nakayama T, Furutani Y, Hayama E, Inai K, Saji T, Nonoyama S, Nakanishi T: Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension. Circ J. 2012, 76: 1501-1508. 10.1253/circj.CJ-11-1281.PubMedCrossRef
36.
go back to reference Shintani M, Yagi H, Nakayama T, Saji T, Matsuoka R: A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. J Med Genet. 2009, 46: 331-337. 10.1136/jmg.2008.062703.PubMedCrossRef Shintani M, Yagi H, Nakayama T, Saji T, Matsuoka R: A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. J Med Genet. 2009, 46: 331-337. 10.1136/jmg.2008.062703.PubMedCrossRef
37.
go back to reference Price LC, Wort SJ, Perros F, Dorfmüller P, Huertas A, Montani D, Cohen-Kaminsky S, Humbert M: Inflammation in pulmonary arterial hypertension. Chest. 2012, 141: 210-221. 10.1378/chest.11-0793.PubMedCrossRef Price LC, Wort SJ, Perros F, Dorfmüller P, Huertas A, Montani D, Cohen-Kaminsky S, Humbert M: Inflammation in pulmonary arterial hypertension. Chest. 2012, 141: 210-221. 10.1378/chest.11-0793.PubMedCrossRef
38.
go back to reference Pfeifer AC, Timmer J, Klingmüller U: Systems biology of JAK/STAT signalling. Essays Biochem. 2008, 45: 109-120. 10.1042/BSE0450109.PubMedCrossRef Pfeifer AC, Timmer J, Klingmüller U: Systems biology of JAK/STAT signalling. Essays Biochem. 2008, 45: 109-120. 10.1042/BSE0450109.PubMedCrossRef
39.
go back to reference Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF: Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J. 2005, 26: 1110-1118. 10.1183/09031936.05.00045705.PubMedCrossRef Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF: Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J. 2005, 26: 1110-1118. 10.1183/09031936.05.00045705.PubMedCrossRef
40.
go back to reference Cicalini S, Chinello P, Petrosillo N: HIV infection and pulmonary arterial hypertension. Expert Rev Respir Med. 2011, 5: 257-266. 10.1586/ers.11.10.PubMedCrossRef Cicalini S, Chinello P, Petrosillo N: HIV infection and pulmonary arterial hypertension. Expert Rev Respir Med. 2011, 5: 257-266. 10.1586/ers.11.10.PubMedCrossRef
41.
go back to reference Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M: A USA-based registry for pulmonary arterial hypertension: 1982–2006. Eur Respir J. 2007, 30: 1103-1110. 10.1183/09031936.00042107.PubMedCrossRef Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M: A USA-based registry for pulmonary arterial hypertension: 1982–2006. Eur Respir J. 2007, 30: 1103-1110. 10.1183/09031936.00042107.PubMedCrossRef
42.
go back to reference Maclean MR, Dempsie Y: The serotonin hypothesis of pulmonary hypertension revisited. Adv Exp Med Biol. 2010, 661: 309-322. 10.1007/978-1-60761-500-2_20.PubMedCrossRef Maclean MR, Dempsie Y: The serotonin hypothesis of pulmonary hypertension revisited. Adv Exp Med Biol. 2010, 661: 309-322. 10.1007/978-1-60761-500-2_20.PubMedCrossRef
43.
go back to reference Johnson SR, Granton JT, Mehta S: Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest. 2006, 130: 545-552. 10.1378/chest.130.2.545.PubMedCrossRef Johnson SR, Granton JT, Mehta S: Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest. 2006, 130: 545-552. 10.1378/chest.130.2.545.PubMedCrossRef
45.
46.
go back to reference Königshoff M, Eickelberg O: WNT signaling in lung disease: a failure or a regeneration signal?. Am J Respir Cell Mol Biol. 2010, 42: 21-31. 10.1165/rcmb.2008-0485TR.PubMedCrossRef Königshoff M, Eickelberg O: WNT signaling in lung disease: a failure or a regeneration signal?. Am J Respir Cell Mol Biol. 2010, 42: 21-31. 10.1165/rcmb.2008-0485TR.PubMedCrossRef
47.
go back to reference de Jesus Perez VA, Alastalo TP, Wu JC, Axelrod JD, Cooke JP, Amieva M, Rabinovitch M: Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol. 2009, 184: 83-99. 10.1083/jcb.200806049.PubMedPubMedCentralCrossRef de Jesus Perez VA, Alastalo TP, Wu JC, Axelrod JD, Cooke JP, Amieva M, Rabinovitch M: Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol. 2009, 184: 83-99. 10.1083/jcb.200806049.PubMedPubMedCentralCrossRef
48.
49.
go back to reference Fukumoto Y, Matoba T, Ito A, Tanaka H, Kishi T, Hayashidani S, Abe K, Takeshita A, Shimokawa H: Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart. 2005, 91: 391-392. 10.1136/hrt.2003.029470.PubMedPubMedCentralCrossRef Fukumoto Y, Matoba T, Ito A, Tanaka H, Kishi T, Hayashidani S, Abe K, Takeshita A, Shimokawa H: Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart. 2005, 91: 391-392. 10.1136/hrt.2003.029470.PubMedPubMedCentralCrossRef
50.
go back to reference Norrby K: Mast cells and angiogenesis. APMIS. 2002, 110: 355-371. 10.1034/j.1600-0463.2002.100501.x.PubMedCrossRef Norrby K: Mast cells and angiogenesis. APMIS. 2002, 110: 355-371. 10.1034/j.1600-0463.2002.100501.x.PubMedCrossRef
51.
go back to reference Chen L, Endler A, Shibasaki F: Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors. Exp Mol Med. 2009, 41: 849-857. 10.3858/emm.2009.41.12.103.PubMedPubMedCentralCrossRef Chen L, Endler A, Shibasaki F: Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors. Exp Mol Med. 2009, 41: 849-857. 10.3858/emm.2009.41.12.103.PubMedPubMedCentralCrossRef
Metadata
Title
Gene expression analysis of a murine model with pulmonary vascular remodeling compared to end-stage IPAH lungs
Authors
Kayoko Shimodaira
Yoichiro Okubo
Eri Ochiai
Haruo Nakayama
Harutaka Katano
Megumi Wakayama
Minoru Shinozaki
Takao Ishiwatari
Daisuke Sasai
Naobumi Tochigi
Tetsuo Nemoto
Tsutomu Saji
Katsuhiko Kamei
Kazutoshi Shibuya
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2012
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-13-103

Other articles of this Issue 1/2012

Respiratory Research 1/2012 Go to the issue